AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
Xian Zhang
Public Documents
1
January 20, 2022
Anti-CD19 CAR T as a feasible and safe therapy for refractory/relapsed mixed phenotyp...
Xiangqun Li, Kylann Chen, Hailong Zhang, et al.